Radiopharm Theranostics Ltd (RADX) Form 6-K — Oct 1, 2026
Radiopharm Theranostics filed a Form 6-K on October 1, 2026 disclosing two routine ASX announcements: a change of director's interest notice and a notification of cessation of securities. Director Riccardo Canevari saw 24,000,000 unlisted options expire unexercised on September 30, 2026. The options had a $0.06 exercise price and expired worthless, reducing his options from 187.3 million to 163.3 million while his 26.6 million share position was unchanged. The cessation notice confirms 24 million RADAN options ceased without conversion, with no consideration paid by the company.
Key figures
- Option Expiry
- 30 Sept 2026
- Option Strike
- $0.06
- Options Expired
- 24000000
- Director Shares After Change
- 26568875
- Director Options After Change
- 163301188
- Ordinary Shares Outstanding ASX
- 4710882790
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.